Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
Classement en actions #17926
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
Prix de l'action
$18.20
Dernière synchronisation: 2025-05-09
Capitalisation boursière
$220.35M
Changement (1 jour)
-5.34%
Changement (1 an)
0.00%
Pays
JP
Échange I'rom Group Co., Ltd. (2372)

Catégorie

Bénéfices pour I'rom Group Co., Ltd. (2372)
Bénéfices en Dec 2024 TTM : $9.98M
Selon les derniers rapports financiers de I'rom Group Co., Ltd., les bénéfices actuels de l'entreprise sont de $9.98M. En 2023, l'entreprise a réalisé un bénéfice de $25.17M, une augmentation par rapport à celui de 2022 qui était de $21.24M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour I'rom Group Co., Ltd. de 2005 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $9.98M -23.16%
2024 $12.99M -48.39%
2023 $25.17M 18.51%
2022 $21.24M 39.44%
2021 $15.23M 45.30%
2020 $10.48M -1.23%
2019 $10.61M -38.18%
2018 $17.17M 595.33%
2017 $2.47M -134.25%
2016 $-7.21M 43.61%
2015 $-5.02M 55.00%
2014 $-3.24M -117.10%
2013 $18.94M -1,247.10%
2012 $-1.65M -227.92%
2011 $1.29M -117.79%
2010 $-7.26M -93.02%
2009 $-104.01M 912.86%
2008 $-10.27M 79.68%
2007 $-5.72M -184.52%
2006 $6.76M -56.10%
2005 $15.40M 0.00%
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
$9.87B 98,800.88%
US
- -
DE
$687.82M 6,791.50%
SA
$3.87B 38,624.74%
US
- -
MY